Literature DB >> 23243281

Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection.

Edwin Leeansyah1, Anupama Ganesh, Máire F Quigley, Anders Sönnerborg, Jan Andersson, Peter W Hunt, Ma Somsouk, Steven G Deeks, Jeffrey N Martin, Markus Moll, Barbara L Shacklett, Johan K Sandberg.   

Abstract

Mucosal-associated invariant T (MAIT) cells are an evolutionarily conserved antimicrobial MR1-restricted T-cell subset. MAIT cells are CD161(+), express a V7.2 TCR, are primarily CD8(+) and numerous in blood and mucosal tissues. However, their role in HIV-1 infection is unknown. In this study, we found levels of MAIT cells to be severely reduced in circulation in patients with chronic HIV-1 infection. Residual MAIT cells were highly activated and functionally exhausted. Their decline was associated with time since diagnosis, activation levels, and the concomitant expansion of a subset of functionally impaired CD161(+) V7.2(+) T cells. Such cells were generated in vitro by exposure of MAIT cells to Escherichia coli. Notably, whereas the function of residual MAIT cells was at least partly restored by effective antiretroviral therapy, levels of MAIT cells in peripheral blood were not restored. Interestingly, MAIT cells in rectal mucosa were relatively preserved, although some of the changes seen in blood were recapitulated in the mucosa. These findings are consistent with a model in which the MAIT-cell compartment, possibly as a result of persistent exposure to microbial material, is engaged, activated, exhausted, and progressively and persistently depleted during chronic HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23243281      PMCID: PMC3575756          DOI: 10.1182/blood-2012-07-445429

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

1.  The mechanism underlying defective Fcgamma receptor-mediated phagocytosis by HIV-1-infected human monocyte-derived macrophages.

Authors:  Edwin Leeansyah; Bruce D Wines; Suzanne M Crowe; Anthony Jaworowski
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

2.  HIV-1 down-modulates gamma signaling chain of Fc gamma R in human macrophages: a possible mechanism for inhibition of phagocytosis.

Authors:  Katherine Kedzierska; Philip Ellery; Johnson Mak; Sharon R Lewin; Suzanne M Crowe; Anthony Jaworowski
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

3.  Antimicrobial activity of mucosal-associated invariant T cells.

Authors:  Lionel Le Bourhis; Emmanuel Martin; Isabelle Péguillet; Amélie Guihot; Nathalie Froux; Maxime Coré; Eva Lévy; Mathilde Dusseaux; Vanina Meyssonnier; Virginie Premel; Charlotte Ngo; Béatrice Riteau; Livine Duban; Delphine Robert; Shouxiong Huang; Martin Rottman; Claire Soudais; Olivier Lantz
Journal:  Nat Immunol       Date:  2010-06-27       Impact factor: 25.606

4.  Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection.

Authors:  R S Veazey; M DeMaria; L V Chalifoux; D E Shvetz; D R Pauley; H L Knight; M Rosenzweig; R P Johnson; R C Desrosiers; A A Lackner
Journal:  Science       Date:  1998-04-17       Impact factor: 47.728

5.  Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.

Authors:  Moraima Guadalupe; Elizabeth Reay; Sumathi Sankaran; Thomas Prindiville; Jason Flamm; Andrew McNeil; Satya Dandekar
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration.

Authors:  Sumathi Sankaran; Michael D George; Elizabeth Reay; Moraima Guadalupe; Jason Flamm; Thomas Prindiville; Satya Dandekar
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

7.  Optimization of methods to assess human mucosal T-cell responses to HIV infection.

Authors:  Barbara L Shacklett; Otto Yang; Mary Ann Hausner; Julie Elliott; Lance Hultin; Charles Price; Marie Fuerst; Jose Matud; Patricia Hultin; Catherine Cox; Javier Ibarrondo; Johnson T Wong; Douglas F Nixon; Peter A Anton; Beth D Jamieson
Journal:  J Immunol Methods       Date:  2003-08       Impact factor: 2.303

8.  Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1.

Authors:  Emmanuel Treiner; Livine Duban; Seiamak Bahram; Mirjana Radosavljevic; Valerie Wanner; Florence Tilloy; Pierre Affaticati; Susan Gilfillan; Olivier Lantz
Journal:  Nature       Date:  2003-03-13       Impact factor: 49.962

9.  Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infection.

Authors:  Barbara L Shacklett; Catherine A Cox; Máire F Quigley; Christophe Kreis; Neil H Stollman; Mark A Jacobson; Jan Andersson; Johan K Sandberg; Douglas F Nixon
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

10.  Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract.

Authors:  Saurabh Mehandru; Michael A Poles; Klara Tenner-Racz; Amir Horowitz; Arlene Hurley; Christine Hogan; Daniel Boden; Paul Racz; Martin Markowitz
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  183 in total

Review 1.  MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?

Authors:  Stanislas Mondot; Pierre Boudinot; Olivier Lantz
Journal:  Immunogenetics       Date:  2016-07-08       Impact factor: 2.846

2.  Clonal enrichments of Vδ2- γδ T cells in Mycobacterium tuberculosis-infected human lungs.

Authors:  Corinna A Kulicke; Deborah A Lewinsohn; David M Lewinsohn
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

Review 3.  Innate-like lymphocytes in intestinal infections.

Authors:  Michael S Bennett; June L Round; Daniel T Leung
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

4.  Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines.

Authors:  Joana Dias; Edwin Leeansyah; Johan K Sandberg
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

5.  Mucosa-Associated Invariant T Cells Are Systemically Depleted in Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Carol Vinton; Fan Wu; Jamie Rossjohn; Kenta Matsuda; James McCluskey; Vanessa Hirsch; David A Price; Jason M Brenchley
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 6.  The role of mucosal-associated invariant T cells in infectious diseases.

Authors:  Emily B Wong; Thumbi Ndung'u; Victoria O Kasprowicz
Journal:  Immunology       Date:  2016-10-26       Impact factor: 7.397

7.  Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells.

Authors:  Joana Dias; Julia Hengst; Tiphaine Parrot; Edwin Leeansyah; Sebastian Lunemann; David F G Malone; Svenja Hardtke; Otto Strauss; Christine L Zimmer; Lena Berglin; Thomas Schirdewahn; Sandra Ciesek; Nicole Marquardt; Thomas von Hahn; Michael P Manns; Markus Cornberg; Hans-Gustaf Ljunggren; Heiner Wedemeyer; Johan K Sandberg; Niklas K Björkström
Journal:  J Hepatol       Date:  2019-05-14       Impact factor: 25.083

8.  High expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT cells.

Authors:  Prabhat K Sharma; Emily B Wong; Ruth J Napier; William R Bishai; Thumbi Ndung'u; Victoria O Kasprowicz; Deborah A Lewinsohn; David M Lewinsohn; Marielle C Gold
Journal:  Immunology       Date:  2015-03-29       Impact factor: 7.397

9.  Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition.

Authors:  Mérédis Favreau; Koen Venken; Sylvia Faict; Ken Maes; Kim De Veirman; Elke De Bruyne; Xavier Leleu; Louis Boon; Dirk Elewaut; Karin Vanderkerken; Eline Menu
Journal:  Haematologica       Date:  2017-04-06       Impact factor: 9.941

10.  Persistent immune activation in chronic HIV infection: do any interventions work?

Authors:  Reena Rajasuriar; Gabriela Khoury; Adeeba Kamarulzaman; Martyn A French; Paul U Cameron; Sharon R Lewin
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.